BIOTIME INC Business Finance Contracts & Agreements
89 Contracts & Agreements
- Credit Agreements (10 contracts)
- Escrow Agreements (1)
- Exchange Agreements (2)
- Note Agreements (4)
- Purchase Agreements (5)
- Registration Rights Agreements (3)
- Security Agreements (4)
- Share Agreements (6)
- Shareholders Agreements (2)
- Stock Agreements (30)
- Subscription Agreements (2)
- Underwriting Agreements (5)
- Warrant Agreements (15)
- Amendment to Stock Option Agreements dated December 4, 2023 between Registrant and Gary S. Hogge (Filed With SEC on March 7, 2024)
- Form of Stock Purchase Agreement (Filed With SEC on February 6, 2024)
- Share Purchase and Transfer Agreement, dated June 16, 2017, by and among registrant, HBL-Hadasit Bio-Holdings Ltd. and Cell Cure Neurosciences Ltd (Filed With SEC on June 17, 2022)
- Debt and Note Purchase Agreement, dated June 16, 2017, and Amendment to Debt and Note Purchase Agreement, dated as of June 29, 2017, between registrant and HBL-Hadasit... (Filed With SEC on June 17, 2022)
- Description of Capital Stock of the Registrant (Filed With SEC on March 11, 2021)
- 2012 Plan Form of Restricted Stock Unit (Filed With SEC on March 12, 2020)
- Description of Capital Stock of the Registrant (Filed With SEC on March 12, 2020)
- Shareholder Agreement, dated August 30, 2018 between BioTime, Inc. and Juvenescence Limited (Filed With SEC on August 31, 2018)
- Convertible Promissory Note, dated August 30, 2018 (Filed With SEC on August 31, 2018)
- Stock Purchase Agreement, dated August 30, 2018, between BioTime, Inc., AgeX Therapeutics, Inc. and Juvenescence Limited (Filed With SEC on August 31, 2018)
- Option to Purchase Shares of AgeX Therapeutics, Inc., dated August 4, 2017, granted by BioTime, Inc. to Alfred D. Kingsley (Filed With SEC on November 9, 2017)
- Form of AgeX Therapeutics, Inc. Stock Option Agreement (Filed With SEC on October 16, 2017)
- Underwriting Agreement, dated October 13, 2017, by and between BioTime, Inc. and Raymond James & Associates, Inc., as representative of the underwriters named therein (Filed With SEC on October 13, 2017)
- Share Purchase and Transfer Agreement, dated June 16, 2017, by and among BioTime, Inc. and HBL-Hadasit Bio-Holdings Ltd. and Cell Cure Neurosciences Ltd. (Portions of this exhibit... (Filed With SEC on August 9, 2017)
- Debt and Note Purchase Agreement, dated June 16, 2017, as amended June 29, 2017, between BioTime, Inc. and HBL-Hadasit Bio-Holdings Ltd. (Portions of this exhibit have been... (Filed With SEC on August 9, 2017)
- Form of Cell Cure Neurosciences Ltd. Share Option Plan Option Agreement (Filed With SEC on March 16, 2017)
- Cell Cure Neurosciences Ltd. Share Option Plan (Filed With SEC on March 16, 2017)
- Underwriting Agreement, dated February 10, 2017, between BioTime, Inc. and Raymond James & Associates, Inc., as representative of the underwriters named therein (Filed With SEC on February 13, 2017)
- Form of Warrant (Filed With SEC on August 29, 2016)
- Alternate Form of Securities Purchase Agreement (Filed With SEC on August 29, 2016)
- Form of Securities Purchase Agreement (Filed With SEC on August 29, 2016)
- Underwriting Agreement, dated June 16, 2016, between BioTime, Inc. and Oppenheimer & Co. Inc (Filed With SEC on June 17, 2016)
- Warrant Agreement between Asterias Biotherapeutics, Inc. and American Stock Transfer & Trust Company (Filed With SEC on May 10, 2016)
- Share Transfer Agreement by and among Asterias Biotherapeutics, Inc., BioTime, Inc., and ES Cell International Pte Ltd (Filed With SEC on February 18, 2016)
- Subscription Agreement, dated September 29, 2015, between OncoCyte Corporation and BioTime, Inc (Filed With SEC on November 9, 2015)
- Stock Purchase Agreements between BioTime, Inc. and certain investors (Filed With SEC on November 9, 2015)
- Stock Purchase Agreements, dated September 14, 2015, between BioTime, Inc. and certain investors (Filed With SEC on November 9, 2015)
- STOCK PURCHASE AGREEMENT (Filed With SEC on October 2, 2015)
- Letter Agreement with Union Underwriting & Finances Ltd (Filed With SEC on September 25, 2015)
- Form of Escrow Agreement (Filed With SEC on September 25, 2015)
- Form of Stock Purchase Agreements (Filed With SEC on September 25, 2015)
- STOCK PURCHASE AGREEMENT (Filed With SEC on September 14, 2015)
- Subscription Agreements between Asterias Biotherapeutics, Inc. and the investors named therein (Filed With SEC on March 11, 2015)
- Underwriting Agreement, dated February 5, 2015, by and between Asterias Biotherapeutics, Inc. and MLV & Co. LLC (Filed With SEC on February 6, 2015)
- Form of Stock Purchase Agreement (Filed With SEC on October 3, 2014)
- Warrant Agreement, dated October 1, 2013, as amended September 19, 2014, between BioTime, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on September 23, 2014)
- Form of LifeMap Solutions, Inc. Stock Option Agreement (Filed With SEC on August 11, 2014)
- LifeMap Solutions, Inc. 2014 Stock Option Plan (Filed With SEC on August 11, 2014)
- Registration Rights Agreement, dated June 16, 2014, between The George Karfunkel 2007 Grantor Trust #1, Broadwood Partners, L.P., and Asterias Biotherapeutics, Inc (Filed With SEC on August 11, 2014)
- Purchase Agreement, dated June 13, 2014, between The George Karfunkel 2007 Grantor Trust #1 and Asterias Biotherapeutics, Inc (Filed With SEC on August 11, 2014)